Fibrolamellar hepatocellular carcinoma - Prolonged survival with multimodality therapy

European Journal of Surgical Oncology

Volumn 35, Issue 6, 2009, Pages 617-621

  Maniaci, V ^a   Davidson, B R ^b   Rolles, K ^b   Dhillon, A P ^b   Hackshaw, A ^c   Begent, R H ^a   Meyer, T ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

^c IMPERIAL CANCER RESEARCH FUND   (United Kingdom)

Author keywords

Chemotherapy; FDG PET; Fibrolamellar; Hepatocellular; Liver cancer; Surgery

Indexed keywords

CAPECITABINE; CARBOPLATIN; CISPLATIN; DOXORUBICIN; FLUORODEOXYGLUCOSE F 18; FLUOROURACIL; IODINATED POPPYSEED OIL I 131; OXALIPLATIN; PACLITAXEL; RADIOPHARMACEUTICAL AGENT; TAMOXIFEN; THALIDOMIDE; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; ARTICLE; CANCER RADIOTHERAPY; CANCER RELAPSE; CLINICAL ARTICLE; FEMALE; FIBROLAMELLAR LIVER CELL CARCINOMA; HUMAN; LIVER CELL CARCINOMA; LIVER RESECTION; MALE; MULTIMODALITY CANCER THERAPY; MULTIPLE CYCLE TREATMENT; OUTCOME ASSESSMENT; OVERALL SURVIVAL; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RARE DISEASE; RECURRENCE RISK;

ADOLESCENT; ADULT; CARCINOMA, HEPATOCELLULAR; COMBINED MODALITY THERAPY; FEMALE; HEPATECTOMY; HUMANS; LIVER NEOPLASMS; LYMPH NODE EXCISION; MALE; MIDDLE AGED; SURVIVAL ANALYSIS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 67349170783     PISSN: 07487983     EISSN: 15322157     Source Type: Journal    
DOI: 10.1016/j.ejso.2008.12.009     Document Type: Article

References (25)

1. Edmondson H.A. Differential diagnosis of tumors and tumor-like lesions of liver in infancy and childhood. AMA J Dis Child 91 2 (1956) 168-186
2. Craig J.R., Peters R.L., Edmondson H.A., and Omata M. Fibrolamellar carcinoma of the liver: a tumor of adolescents and young adults with distinctive clinico-pathologic features. Cancer 46 2 (1980) 372-379
3. Berman M.M., Libbey N.P., and Foster J.H. Hepatocellular carcinoma. Polygonal cell type with fibrous stroma - an atypical variant with a favorable prognosis. Cancer 46 6 (1980) 1448-1455
4. Wilkens L., Bredt M., Flemming P., Kubicka S., Klempnauer J., and Kreipe H. Cytogenetic aberrations in primary and recurrent fibrolamellar hepatocellular carcinoma detected by comparative genomic hybridization. Am J Clin Pathol 114 6 (2000) 867-874
5. Honda K., Sbisa E., Tullo A., et al. P53 mutation is a poor prognostic indicator for survival in patients with hepatocellular carcinoma undergoing surgical tumour ablation. Br J Cancer 77 5 (1998) 776-782
6. Vivekanandan P., and Torbenson M. Epigenetic instability is rare in fibrolamellar carcinomas but common in viral-associated hepatocellular carcinomas. Mod Pathol 21 6 (2008) 670-675
7. Sirivatanauksorn Y., Sirivatanauksorn V., Lemoine N.R., Williamson R.C., and Davidson B.R. Genomic homogeneity in fibrolamellar carcinomas. Gut 49 1 (2001) 82-86
8. El-Serag H.B., and Davila J.A. Is fibrolamellar carcinoma different from hepatocellular carcinoma? A US population-based study. Hepatology 39 3 (2004) 798-803
9. Pinna A.D., Iwatsuki S., Lee R.G., et al. Treatment of fibrolamellar hepatoma with subtotal hepatectomy or transplantation. Hepatology 26 4 (1997) 877-883
10. Paradinas F.J., Melia W.M., Wilkinson M.L., et al. High serum vitamin B12 binding capacity as a marker of the fibrolamellar variant of hepatocellular carcinoma. Br Med J (Clin Res Ed) 285 6345 (1982) 840-842
11. Kanai T., Takabayashi T., Kawano Y., Kuramochi S., and Miyazawa N. A case of postoperative recurrence of fibrolamellar hepatocellular carcinoma with increased vitamin B12 binding capacity in a young Japanese female. Jpn J Clin Oncol 34 6 (2004) 346-351
12. Saab S., and Yao F. Fibrolamellar hepatocellular carcinoma. Case reports and a review of the literature. Dig Dis Sci 41 10 (1996) 1981-1985
13. Stevens W.R., Johnson C.D., Stephens D.H., and Nagorney D.M. Fibrolamellar hepatocellular carcinoma: stage at presentation and results of aggressive surgical management. AJR Am J Roentgenol 164 5 (1995) 1153-1158
14. Stipa F., Yoon S.S., Liau K.H., et al. Outcome of patients with fibrolamellar hepatocellular carcinoma. Cancer 106 6 (2006) 1331-1338
15. Ichikawa T., Federle M.P., Grazioli L., and Marsh W. Fibrolamellar hepatocellular carcinoma: pre- and posttherapy evaluation with CT and MR imaging. Radiology 217 1 (2000) 145-151
16. Torbenson M. Review of the clinicopathologic features of fibrolamellar carcinoma. Adv Anat Pathol 14 3 (2007) 217-223
17. El-Gazzaz G., Wong W., El-Hadary M.K., et al. Outcome of liver resection and transplantation for fibrolamellar hepatocellular carcinoma. Transpl Int 13 Suppl. 1 (2000) S406-S409
18. Kakar S., Burgart L.J., Batts K.P., et al. Clinicopathologic features and survival in fibrolamellar carcinoma: comparison with conventional hepatocellular carcinoma with and without cirrhosis. Mod Pathol 18 11 (2005) 1417-1423
19. Soreide O., Czerniak A., Bradpiece H., Bloom S., and Blumgart L. Characteristics of fibrolamellar hepatocellular carcinoma. A study of nine cases and a review of the literature. Am J Surg 151 4 (1986) 518-523
20. Khan M.A., Combs C.S., Brunt E.M., et al. Positron emission tomography scanning in the evaluation of hepatocellular carcinoma. J Hepatol 32 5 (2000) 792-797
21. Sugiyama M., Sakahara H., Torizuka T., et al. 18F-FDG PET in the detection of extrahepatic metastases from hepatocellular carcinoma. J Gastroenterol 39 10 (2004) 961-968
22. Wood W.J., Rawlings M., Evans H., and Lim C.N. Hepatocellular carcinoma: importance of histologic classification as a prognostic factor. Am J Surg 155 5 (1988) 663-666
23. Katzenstein H.M., Krailo M.D., Malogolowkin M.H., et al. Fibrolamellar hepatocellular carcinoma in children and adolescents. Cancer 97 8 (2003) 2006-2020
24. Nagorney D.M., Adson M.A., Weiland L.H., et al. Fibrolamellar hepatoma. Am J Surg 149 1 (1985) 113-119
25. Llovet J.M., Ricci S., Mazzaferro V., et al. Sorafenib in advanced hepatocellular carcinoma. N Engl J Med 359 4 (2008) 378-390